Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · IEX Real-Time Price · USD
6.72
+0.20 (3.07%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $123.35 million as of July 22, 2024. Its market cap has decreased by -49.24% in one year.
Market Cap
123.35M
Enterprise Value
103.89M
1-Year Change
-49.24%
Ranking
Category
Stock Price
$6.72
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $123.35M, an increase of 112.66%. That is a compound annual growth rate of 35.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 123.40M | -14.60% |
| Dec 29, 2023 | 144.50M | 31.60% |
| Dec 30, 2022 | 109.80M | 89.29% |
| Feb 4, 2022 | 58.01M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 127.46M |
| Immunic | 127.01M |
| Annovis Bio | 126.57M |
| Agenus | 125.79M |
| Relmada Therapeutics | 125.52M |
| Athira Pharma | 119.20M |
| Werewolf Therapeutics | 118.20M |
| Seer, Inc. | 116.89M |